Nektar Therapeutics
NKTR
#4943
Rank
A$2.84 B
Marketcap
A$83.42
Share price
-3.39%
Change (1 day)
-6.81%
Change (1 year)

Nektar Therapeutics (NKTR) - Net assets

Net assets on the balance sheet as of June 2026 : A$1.29 Billion

According to Nektar Therapeutics 's latest financial reports the company has A$1.29 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Nektar Therapeutics - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$0.13 B37.35%
2024-12-31$A$97.64 M-49.21%
2023-12-31$A$0.19 B-64.32%
2022-12-31$A$0.53 B-42.52%
2021-12-31$A$0.93 B-33.1%
2020-12-31$A$1.40 B-30.2%
2019-12-31$A$2.00 B-17.67%
2018-12-31$A$2.43 B2067.22%
2017-12-31$A$0.11 B-7.98%
2016-12-31$A$0.12 B1285.32%
2015-12-31$A$8.82 M-80.12%
2014-12-31$A$44.39 M-144.05%
2013-12-31$-A$0.11 Billion-322.77%
2012-12-31$A$45.24 M-76.55%
2011-12-31$A$0.19 B116.15%
2010-12-31$A$89.25 M-21.68%
2009-12-31$A$0.11 B-57.72%
2008-12-31$A$0.26 B9.89%
2007-12-31$A$0.24 B-14.85%
2006-12-31$A$0.28 B-35.51%
2005-12-31$A$0.44 B-26.04%
2004-12-31$A$0.60 B173.4%
2003-12-31$A$0.22 B-39.81%
2002-12-31$A$0.36 B-30.71%
2001-12-31$A$0.52 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
A$121.48 B 9,308.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$122.22 B 9,366.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.71 B 1,194.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$8.83 B 584.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$60.02 B 4,548.77%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$72.01 B 5,477.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$0.23 B-81.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$2.50 B 93.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland